NCT04320940 - Efficacy and Safety of Intravenous Phenobarbital in Neonatal Seizures | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 12, 2021

Primary Completion Date

February 1, 2023

Study Completion Date

February 1, 2023

Conditions

Epilepsy, Benign Neonatal

Interventions

DRUG

Phenobarbital Sodium Injection

The initial dose will be administered intravenously over a 30-minute period. The time period between the first and second dose of phenobarbital cannot occur within 30 minutes of the end of the first dose.

Trial Locations (8)

15213

Matthew Butoryak, Pittsburgh

15224

UPMC Children's Hospital of Pittsburgh, Pittsburgh

20010

Children's National Hospital, Washington D.C.

22110

Jordan University of Science and Technology (King Abdullah University Hospital, KAUH), Irbid

25701

Marshall Health, Huntington

33143

South Miami Hospital, Miami

33606

Jamie Flores-Torres, Tampa

72202

Arkansas Cildren's Hospital, Little Rock